# Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease

> **NCT07522645** · NA · NOT_YET_RECRUITING · sponsor: **Kaiser Permanente** · enrollment: 22000 (estimated)

## Conditions studied

- ASCVD
- Diabetes

## Interventions

- **BEHAVIORAL:** SMS (Initial Outreach)
- **BEHAVIORAL:** Secure Portal Message (Initial Outreach)
- **BEHAVIORAL:** Non-secure Email (Initial Outreach)
- **BEHAVIORAL:** SMS (Follow-up for Non-responders)
- **BEHAVIORAL:** Secure Portal Message (Follow-up for Non-responders)
- **BEHAVIORAL:** Non-secure Email (Follow-up for Non-responders)

## Key facts

- **NCT ID:** NCT07522645
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2026-05-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 22000 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07522645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07522645, "Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07522645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*